Dr Harold A Fuselier, MD | |
2820 Napoleon Ave, Suite 890, New Orleans, LA 70115-6969 | |
(504) 412-1366 | |
(504) 412-1367 |
Full Name | Dr Harold A Fuselier |
---|---|
Gender | Male |
Speciality | Urology |
Location | 2820 Napoleon Ave, New Orleans, Louisiana |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023066107 | NPI | - | NPPES |
00012272 | Medicaid | MS | |
1138533 | Medicaid | LA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | MD.010551 (Louisiana) | Primary |
Entity Name | Louisiana State University School Of Medicine In New Orleans Faculty G |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1477582526 PECOS PAC ID: 0244136448 Enrollment ID: O20031209000661 |
News Archive
Trubion Pharmaceuticals, Inc. today announced favorable safety and efficacy data following administration of a second course (R2) of re-treatment with 800 mg of TRU-015 for rheumatoid arthritis (RA). These data are the latest results from the ongoing open-label re-treatment portion of the Phase 2b (15002) RA study of TRU-015. Pfizer Inc. and Trubion are collaborating on the development of TRU-015 for the treatment of autoimmune and inflammatory diseases, including RA.
The Good News Care Center, located in Florida City, is pleased to announce a $50,000 grant received from Health Foundation of South Florida for the Coming Home: ER Diversion and Medical Homes Project, an initiative that increases the provision of primary care services, and integrates primary and tertiary medical care intervention with health education.
Two new studies presented today at the European League Against Rheumatism Annual Congress have helped clarify the relationship between the dietary intake of monounsaturated fatty acids and cholesterol with disease activity in rheumatoid arthritis (RA) and osteoarthritis (OA) respectively.
An international research team has identified four likely new subtypes of a rare brain tumor using molecular techniques that lay the foundation for more accurate diagnosis and tailored therapies for the hard-to-treat cancer. Scientists at St. Jude Children's Research Hospital and the German Cancer Research Center led the study, results of which appear today in the scientific journal Cell.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Harold A Fuselier, MD 1340 Poydras St, Suite 1640, New Orleans, LA 70112-1221 Ph: (504) 412-1835 | Dr Harold A Fuselier, MD 2820 Napoleon Ave, Suite 890, New Orleans, LA 70115-6969 Ph: (504) 412-1366 |
News Archive
Trubion Pharmaceuticals, Inc. today announced favorable safety and efficacy data following administration of a second course (R2) of re-treatment with 800 mg of TRU-015 for rheumatoid arthritis (RA). These data are the latest results from the ongoing open-label re-treatment portion of the Phase 2b (15002) RA study of TRU-015. Pfizer Inc. and Trubion are collaborating on the development of TRU-015 for the treatment of autoimmune and inflammatory diseases, including RA.
The Good News Care Center, located in Florida City, is pleased to announce a $50,000 grant received from Health Foundation of South Florida for the Coming Home: ER Diversion and Medical Homes Project, an initiative that increases the provision of primary care services, and integrates primary and tertiary medical care intervention with health education.
Two new studies presented today at the European League Against Rheumatism Annual Congress have helped clarify the relationship between the dietary intake of monounsaturated fatty acids and cholesterol with disease activity in rheumatoid arthritis (RA) and osteoarthritis (OA) respectively.
An international research team has identified four likely new subtypes of a rare brain tumor using molecular techniques that lay the foundation for more accurate diagnosis and tailored therapies for the hard-to-treat cancer. Scientists at St. Jude Children's Research Hospital and the German Cancer Research Center led the study, results of which appear today in the scientific journal Cell.
› Verified 1 days ago
Carrie Aline Stewart, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1430 Tulane Ave, New Orleans, LA 70112 Phone: 256-658-1406 | |
Dr. Nathan Samuel Wexler, M.D. Urology Medicare: Medicare Enrolled Practice Location: 6050 Annunciation St, New Orleans, LA 70118 Phone: 504-897-3088 Fax: 504-891-1326 | |
Dr. David C Benson, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2000 Canal St Fl 5, New Orleans, LA 70112 Phone: 504-702-4333 | |
Dr. Raju Thomas, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1415 Tulane Ave, Urology Clinic, New Orleans, LA 70112 Phone: 504-988-2300 Fax: 504-988-7655 | |
Louis Spencer Krane, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1430 Tulane Ave, New Orleans, LA 70112 Phone: 504-988-2750 | |
Dr. Aaron D Martin, M.D., M.P.H Urology Medicare: Accepting Medicare Assignments Practice Location: 200 Henry Clay Ave, New Orleans, LA 70118 Phone: 504-896-9233 Fax: 504-896-9861 |